2012
DOI: 10.1111/j.1365-2362.2012.02657.x
|View full text |Cite
|
Sign up to set email alerts
|

Reverse iontophoresis of urea in health and chronic kidney disease: a potential diagnostic and monitoring tool?

Abstract: BackgroundPatients with chronic kidney disease (CKD) need regular monitoring, usually by blood urea and creatinine measurements, needing venepuncture, frequent attendances and a healthcare professional, with significant inconvenience. Noninvasive monitoring will potentially simplify and improve monitoring. We tested the potential of transdermal reverse iontophoresis of urea in patients with CKD and healthy controls.MethodsUsing a MIC 2® Iontophoresis Controller, reverse iontophoresis was applied on the forearm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 31 publications
0
4
0
Order By: Relevance
“…Upon application of an electric field in iontophoresis, three contributions to the total flux of the target compound are possible [29]: (i) electromigration, whereby charged species are electrostatically repelled from an electrode of like polarity and attracted to one of the opposite charge [28]; (ii) electroosmosis, which is a net flow of solvent across the skin in the anode-to-cathode direction and results when the electric field is applied across the net negatively-charged skin (pI ~4.0 to 4.5) [28]; and (iii) passive diffusion, which for amino acids is significantly lower relative to electromigration and electroosmosis [30]. This minimally invasive technique has been shown effective for the monitoring of drugs [31], the constituents of natural moisturizing factor (NMF) [32][33][34][35], glucose [36,37], phenylalanine (to diagnose phenylketonuria [38], urea (as a biomarker of chronic kidney disease) [39], and prostaglandin E2 (a molecule associated with cutaneous inflammation) [40]. As most amino acids are zwitterionic at pH 7.4, electroosmosis towards the cathode on the skin surface is the primary mechanism by which they are extracted transdermally in reverse iontophoresis [28,32,34,41].…”
Section: Introductionmentioning
confidence: 99%
“…Upon application of an electric field in iontophoresis, three contributions to the total flux of the target compound are possible [29]: (i) electromigration, whereby charged species are electrostatically repelled from an electrode of like polarity and attracted to one of the opposite charge [28]; (ii) electroosmosis, which is a net flow of solvent across the skin in the anode-to-cathode direction and results when the electric field is applied across the net negatively-charged skin (pI ~4.0 to 4.5) [28]; and (iii) passive diffusion, which for amino acids is significantly lower relative to electromigration and electroosmosis [30]. This minimally invasive technique has been shown effective for the monitoring of drugs [31], the constituents of natural moisturizing factor (NMF) [32][33][34][35], glucose [36,37], phenylalanine (to diagnose phenylketonuria [38], urea (as a biomarker of chronic kidney disease) [39], and prostaglandin E2 (a molecule associated with cutaneous inflammation) [40]. As most amino acids are zwitterionic at pH 7.4, electroosmosis towards the cathode on the skin surface is the primary mechanism by which they are extracted transdermally in reverse iontophoresis [28,32,34,41].…”
Section: Introductionmentioning
confidence: 99%
“…This implies that non-invasive urea detection is useful not only for CKD diagnosis but also for assessing dialysis efficiency. 197 The potential of RI for ISF urea detection was explored using a screen-printed potentiometric sensor wherein urease was immobilized on a micro-structured polypyrene (PPy) matrix that displayed excellent linearity in the range of 10–5000 mM with stable performance for up to 40 days. 198 However, calibration was required, and a few subjects experienced tingling sensations and erythema.…”
Section: Sweat- and Isf-based Biosensors For Ambulatory Carementioning
confidence: 99%
“…Later, iohexol also proved as a successful transcutaneous marker for RI measurement. Intravenous (IV) bolus injection of iohexol is monitored over 6 hours, and the sample, which is collected by the transdermal patch, is analyzed using UV-HPLC [8,9]. Nevertheless, these methods remain time-consuming and call for a much rapid detection method.…”
Section: Gfr Markersmentioning
confidence: 99%